Prediction of ultrafiltration volume in peritoneal dialysis patients
By employing pressure sensors to measure intraperitoneal pressure and using formulas to determine IPV changes, the method addresses the lack of UFV control in peritoneal dialysis, enhancing treatment precision and safety.
Patent Information
- Application Number
- JP2024532401
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-11-30
- Filing Date
- 2022-11-30
- Publication Date
- 2024-12-06
AI Technical Summary
Current peritoneal dialysis methods lack efficient tools for measuring and controlling ultrafiltration volume (UFV) due to the variability of individual peritoneal properties and the absence of adequate monitoring tools, leading to potential fluid overload or dehydration risks.
A method and system for monitoring intraperitoneal volume (IPV) using pressure sensors to measure intraperitoneal pressure (IPP) and determine changes in IPV through formulas involving gravitational acceleration, vertical distance, and dialysate density, allowing for precise UFV prediction during the dwell phase.
Enables accurate and continuous monitoring of IPV and UFV, facilitating tighter control of ultrafiltration rates, reducing the risk of fluid imbalance and improving patient safety by adjusting treatment cycles accordingly.
Smart Images

Figure 2024545413000001_ABST
Abstract
Description
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application claims priority under 35 U.S.C. §119(e) to Provisional Application No. 63 / 284,131, entitled PREDICTING ULTRAFILTRATION VOLUME IN PERITONEAL DIALYSIS PATIENTS, filed November 30, 2021, which is incorporated by reference in its entirety for all purposes. [Background technology]
[0002] Renal dysfunction or failure, and especially end-stage renal disease, causes the body to lose the ability to remove water and minerals, excrete harmful metabolic products, maintain acid-base balance, and control electrolyte and mineral concentrations within physiological ranges. Toxic uremic metabolic waste products, including urea, creatinine, uric acid, and phosphorus, accumulate in body tissues, which can lead to a person's death if the filtering function of the kidneys is not replaced.
[0003] Dialysis is a procedure used to support patients with inadequate kidney function. The two main dialysis methods are hemodialysis and peritoneal dialysis. During hemodialysis ("HD"), the patient's blood passes through a dialyzer in a dialysis machine, and simultaneously, a dialysis solution, or dialysate, passes through the dialyzer. During peritoneal dialysis ("PD"), the patient's peritoneal cavity is periodically infused with dialysate. The membrane lining of the patient's peritoneum acts as a natural semipermeable membrane that allows for diffusion and osmosis exchanges between the solution and the bloodstream. These exchanges through the patient's peritoneum result in the removal of waste products from the blood, including solutes such as urea and creatinine, and regulate the concentrations of other substances in the blood, such as sodium and water. Automated PD machines, called PD cyclers, are designed to control the entire PD process so that it can be performed at home, usually overnight, without the attendance of clinical staff. This process is referred to as continuous cycler-assisted PD ("CCPD"). Many PD cyclers are designed to automatically infuse, dwell, and drain dialysate from a patient's peritoneal cavity. The treatment typically lasts several hours and often begins with an initial drain cycle to remove used or spent dialysate from the peritoneal cavity. The sequence then goes through a succession of sequential fill, dwell, and drain phases. Each phase is called a cycle. Peritoneal dialysis (PD) treatments are increasingly being used in patients with end-stage kidney disease (ESKD) because they can be performed in the patient's home and / or another non-clinical setting.
[0004] In healthy subjects, normal renal function serves to maintain a balanced fluid status, avoiding both overhydration and dehydration. Extended periods of overhydration or dehydration may increase cardiovascular risk. To optimally maintain the fluid status of PD patients, it is advantageous to have the ability to tightly control ultrafiltration to avoid or minimize overhydration or dehydration. In contrast to HD, PD does not have an ultrafiltration pump that can mechanically draw excess fluid from the patient's body tissues. Instead, glucose in the PD dialysate solution provides the osmotic pressure required to drive ultrafiltration. However, PD is less strict than HD in controlling the ultrafiltration rate (UFR) to adjust the ultrafiltration volume (UFV) and adequately remove excess water. This disadvantage of PD is at least partially due to (1) the lack of efficient measurement tools, and (2) a lack of sufficient understanding of the variability of the individual properties of the peritoneum. Summary of the Invention
[0005] According to at least one aspect of the present disclosure, a method is provided for monitoring intraperitoneal volume (IPV) during a dwell period. The method for monitoring IPV during a dwell period includes monitoring intraperitoneal pressure (IPP) during the dwell period using a pressure sensor and determining a change in IPV based at least on a change in IPP during the dwell period. The change in IPV can be determined by:
number
[0006] In general, in one embodiment, a peritoneal dialysis cycler includes a pressure sensor configured to measure intraperitoneal pressure (IPP), one or more hardware processors, and one or more non-transitory computer-readable media having instructions stored thereon that, when executed by the one or more hardware processors, cause the one or more hardware processors to perform operations. The operations include monitoring an intraperitoneal volume (IPV) of a peritoneal dialysis patient during a dwell period by at least monitoring the IPP during the dwell period using the pressure sensor, and determining a change in IPV based at least on the change in IPP during the dwell period. The change in IPV can be determined by:
number
[0007] In general, in one aspect, a system includes at least one device including one or more hardware processors, and one or more non-transitory computer-readable media having instructions stored thereon that, when executed by the one or more hardware processors, cause the one or more hardware processors to perform operations. The operations include monitoring an intraperitoneal volume (IPV) of a peritoneal dialysis patient during a dwell period by at least monitoring an intraperitoneal pressure (IPP) during the dwell period using a pressure sensor, and determining a change in IPV based at least on the change in IPP during the dwell period. The change in IPV can be determined by:
number
[0008] In general, in one aspect, one or more non-transitory computer-readable media store instructions that, when executed by one or more hardware processors, cause the one or more hardware processors to perform operations including: monitoring an intraperitoneal volume (IPV) of a peritoneal dialysis patient during a dwell period by at least monitoring an intraperitoneal pressure (IPP) during the dwell period using a pressure sensor; and determining a change in IPV based at least on the change in IPP during the dwell period. The change in IPV can be determined by:
number
[0009] According to at least one aspect of the present disclosure, a method is provided for monitoring an intraperitoneal volume (IPV) of a fluid during a dwell phase of a peritoneal dialysis treatment. In some examples, the method comprises monitoring an intraperitoneal pressure (IPP) of the fluid during a dwell period using a pressure sensor, measuring a volume and a weight of at least one sample of the fluid during the dwell period, determining a density of the fluid during the dwell period based on the volume and weight of the at least one sample, and determining the IPV based at least on a change in the IPP and a change in density during the dwell period.
[0010] In various instances, IPV can:
number
[0011] According to at least one aspect of the present disclosure, a peritoneal dialysis cycler is provided, which may include a pressure sensor configured to measure an intraperitoneal pressure (IPP) of a fluid, and a controller configured to: monitor an intraperitoneal volume (IPV) of the fluid during a dwell period of a patient by at least monitoring the IPP during the dwell period using the pressure sensor; determine a density of the fluid during the dwell period based on a volume and a weight of at least one sample of the fluid; and determine a change in the IPV based at least on a change in the IPP and a change in the density of the fluid during the dwell period.
[0012] In some examples, the controller:
number
[0013] In accordance with at least one aspect of the present disclosure, a non-transitory computer-readable medium including instructions is provided that direct one or more processors to perform operations comprising: determining an intraperitoneal pressure (IPP) of the fluid during a dwell period using a pressure sensor; determining a change in IPV based at least on the change in IPP of the fluid during the dwell period; determining a density of the fluid during the dwell period based on a volume and weight of at least one sample of the fluid; and determining an intraperitoneal volume (IPV) of the fluid based at least on the change in IPP and the change in density during the dwell period.
[0014] In some examples, the instructions may include instructions to one or more processors:
number
[0015] At least one aspect of the present disclosure provides a method for monitoring an IPV of a fluid during a dwell period. In some examples, the method comprises: determining an IPP of the fluid during the dwell period using a pressure sensor; determining a change in the IPV based at least on the change in the IPP of the fluid during the dwell period; determining a density of the fluid during the dwell period based on a height of the fluid in the peritoneal cavity and a volume of the fluid; and determining an ultrafiltration volume (UFV) of the fluid during the dwell period based on the height. In some examples, the height is determined based on the density and / or the volume.
[0016] These and other objects, features, and advantages of the devices, systems, and methods described herein will become apparent from the following description of specific embodiments thereof, as illustrated in the accompanying drawings. The drawings are not necessarily to scale, emphasis instead being placed on illustrating the principles of the devices, systems, and methods described herein. In the drawings, like reference numbers generally identify corresponding elements. [Brief description of the drawings]
[0017] [Figure 1] 1 illustrates an example of a segmental bioimpedance analysis system for monitoring intraperitoneal volume according to one embodiment. [Diagram 2] FIG. 1 illustrates a schematic diagram of a bench experiment according to one embodiment. [Figure 3A] 1 illustrates a plot of pressure versus height during a bench experiment according to one embodiment. [Figure 3B] 1 illustrates a plot of pressure versus height during a bench experiment according to one embodiment. [Figure 4A] 1 illustrates a plot of intraperitoneal volume (IPV) versus time in a patient during residence according to one embodiment. [Figure 4B] 1 illustrates a plot of intraperitoneal pressure (IPP) versus time in a patient during residence according to one embodiment. [Figure 5A] 1 illustrates a plot of the change in IPP from the start of dwell to the end of dwell according to one embodiment. [Figure 5B]1 illustrates a plot of UFV versus dialysate density measured by a controller (eg, a Liberty cycler) for 14 measurements on 12 individual patients, according to one embodiment. [Figure 6A] 1 illustrates plots of IPP and IPV versus time in eight patients during dwell according to one embodiment. [Figure 6B] 1 illustrates a plot of mean IPP versus mean IPV in eight patients according to one embodiment. [Figure 7A] 1 illustrates a plot of IPP at the start of dwell versus UFV measured by a Liberty cycler (UFVLiberty) according to one embodiment. [Figure 7B] 1 illustrates a plot of IPP vs. UFV at the start of dwell as measured by segmental bioimpedance analysis (UFVSBIA or UFVBIA) according to one embodiment. [Figure 8A] 1 illustrates a plot of UFV versus residence time according to one embodiment. [Figure 8B] 1 illustrates a schematic diagram of a PD system according to one embodiment. [Figure 8C] 1 illustrates a plot of pre-dwell and post-dwell dialysate density according to one embodiment. [Figure 9] FIG. 1 illustrates a block diagram of an example computer system according to one embodiment. [Figure 10] 1 illustrates a schematic diagram of a Connected Health Services ("CHS") system according to one embodiment. [Figure 11] FIG. 1 illustrates a schematic diagram of another bench experiment according to an embodiment. [Figure 12] 12 illustrates a plot of the results of the bench experiment of FIG. 11 according to one embodiment. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0018] Traditionally, in the clinical setting of PD treatment, the total ultrafiltration volume (UFV) is determined from the weight difference between the total filling volume and the total drainage volume at the end of PD treatment. However, the ultrafiltration volume changes throughout the dwell cycle. If the ultrafiltration volume can be monitored during the dwell cycle, a tighter control of the ultrafiltration volume can be achieved. For example, the dwell cycle can be ended early or extended to achieve the target ultrafiltration volume.
[0019] One or more embodiments disclosed herein include components and techniques for predicting ultrafiltration rate (UFV) in peritoneal dialysis patients. Specifically, techniques are described herein for predicting UFV by monitoring intraperitoneal volume (IPV), intraperitoneal pressure (IPP), and / or dialysate density during the dwell cycle. The UFV during dwell can be calculated by the difference between the IPV during dwell and the initial fill volume of dialysate.
[0020] IPP correlates positively with IPV during filling of the peritoneal cavity with dialysate. However, due to the lack of information from previous studies and the difficulty of performing continuous IPV and IPP monitoring during dwell, the relationship between IPP and UFV during the dwell cycle was unclear. In a recent study described below, intraperitoneal volume (IPV) was found to be associated with intraperitoneal pressure (IPP) during the peritoneal dwell cycle. The advantage of using IPP to monitor IPV is that IPP measurements can be monitored automatically and non-invasively throughout the dwell cycle without patient activity.
[0021] For the study, intraperitoneal volume (IPV) during dwell was monitored using segmental bioimpedance analysis (SBIA), which provides insight into UFV dynamics during the dwell cycle of a peritoneal dialysis (PD) treatment. SBIA obtained continuous IPV data while IPP was monitored using a sensor integrated into the PD cycler. For this study, multiple bioimpedance devices (e.g., Hydra4200) were used. Figure 1 illustrates a schematic of how measurements of fluid in the peritoneal cavity were made using eight-point electrodes placed on the patient's torso 100. Measurements on the torso 100 were made using multiple current electrodes 102, multiple measurement electrodes 104, and a right resistance or impedance (R PR ) 106, Left Resistance or Impedance (R PL ) 108. Also illustrated in FIG. 1 is the patient's peritoneum 110 and a controller 112.
[0022] The controller 112 may be coupled to the current electrodes 102 and the measurement electrodes 104. The measurement electrodes 104 may be PR 106 and / or R PL 108. The measurement electrode 104 positioned on the right side of the torso 100 can be coupled to R PR 106 and a measurement electrode 104 positioned on the left side of the torso 100. PL 108.
[0023] The controller 112 may be or include, for example, a Hydra4200 or similar device, and may be configured to monitor the electrodes 102, 104 and resistors 106, 108 and receive information regarding the current and resistance associated with the electrodes 102, 104 and resistors 106, 108. The controller 112 may be configured to calculate the resistances 106, 108, or fluid pressure and / or fluid volume within the peritoneal cavity or associated with the peritoneum 110. As shown, the controller 112 is coupled to the torso 100 via a belt, although the controller 112 need not be coupled to the torso 100. In some examples, the controller 112 may be a separate device capable of operating alone.
[0024] In this example, I1, I3, I2, I4 are current electrodes 102, and S1, S3, S2, S4 are measurement electrodes 104 placed on the right and left sides, respectively. PR 106 and R PL 108 is the resistance at a current frequency of 5 kHz on the right and left side of the abdominal region, respectively. The measuring electrodes 104 may sample at a certain frequency, for example every 2 seconds, during the filling, dwell, and drain phases of the dialysate. The fluid volume in the peritoneal cavity was calculated using Equation 1.
number
[0025] A bench study was also performed to validate the IPP measurements from a sensor integrated into a Liberty cycler with software version 2.9.1C. FIG. 2 illustrates a schematic setup for a bench study 200 performed to test the relationship between pressure change and height level. The bench study 200 included a PD simulator 202, an adjustable table 204 having at least a first height H1 and a second height H2, and a controller 206 (in this study, a Liberty cycler with software version 2.9.1C). On the left side, a first state 201a is illustrated where H1 is greater than H2, and on the right side, a second state 201b is illustrated where H2 is less than H1. An arrow 208 indicates the change from the first state 201a at height H1 of the PD simulator 202 to the second state 201b at height H2 of the PD simulator 202.
[0026] The PD simulator 202 was placed on an adjustable table 204. The adjustable table 204 can transition between various heights, including heights H1 and H2. A controller 206 was coupled to the PD simulator 202 to monitor and / or control the PD simulator 202 and collect IPP pressure measurements. The PD simulator 202 can be configured to simulate and / or emulate the peritoneal cavity, membranes, parietal peritoneum, visceral peritoneum, associated capillaries, veins, and / or arteries, etc., of a human body.
[0027] The principle of the relationship between pressure of a fluid volume, for example the pressure of a fluid volume within PD simulator 202, and the vertical level position of the fluid can be generally described as follows. P=ρ·g·h Equation 2 where P is the pressure from the fluid volume in the vertical direction, ρ is the density of the fluid, and g is the acceleration due to gravity (g ≈ 9.8 m / s 2 ) and h is the height (i.e., the vertical distance between the sensor and the fluid volume). Thus, as the height of the fluid volume varies vertically, P should be linearly correlated with h.
[0028] In some examples, g and h are constants during the dwell phase of a PD treatment. When g and h are constants, changes in intraperitoneal pressure may be primarily associated with changes in dialysate density ρ. It has been found that an increase in IPV in the peritoneal cavity is associated with a decrease in the density of the fluid volume in the peritoneal cavity of the PD simulator 202. The relationship between change in IPV (dIPV) and change in dialysate density can be generally expressed by the following equation: dIPV=-k·dρ Equation 3 where k is a coefficient that can be related to the degree of hydration and the properties of the peritoneal membrane in an individual patient, and dρ is the change in the dialysate density in the peritoneal cavity during dwell. From equations 2 and 3, the relationship between the individual IPV and pressure IPP can be described as follows: dIPP=g h dρ Equation 4
[0029] A combination of Equation 3 and Equation 4 is applied to the relationship between change in pressure and IPV as follows:
number
number
[0030] Equation 6 shows that the change in peritoneal volume is inversely related to the change in intraperitoneal pressure during dwell. Since the UFV of a PD treatment is defined as the change in IPV during dwell, the same relationship between ΔUFV and ΔIPP during dwell shown in Equation 6 applies.
[0031] Generally, in a closed space such as an empty peritoneal cavity without fluid, such as the empty peritoneal cavity of PD simulator 202, pressure is expressed as P0. When the peritoneal cavity is filled with a dialysate solution of density (ρ), the total pressure can be expressed as: P total =P0+(ρ·g·h) Equation 7 Here, P0 represents the initial pressure before new dialysate fills the peritoneal cavity. P0 may depend on the degree of transcapillary hydrostatic pressure and the properties of the peritoneal membrane (e.g., peritoneal membrane 110). In this case, ρ is a constant during the filling phase, so P totalis determined by two factors: the initial pressure (P0) and the dialysate height (h). During the filling phase, more than 2 liters (L) of new dialysate solution is filled into the peritoneal cavity, increasing the dialysate height. Thus, P total can increase with increasing dialysate height in the peritoneal cavity. total The variability of IPP may be based on or related to differences in the initial pressure (P0) of the peritoneal cavity in individual patients. Furthermore, after the filling phase and at the beginning of the dwell phase, excess fluid may begin to move from the capillaries to the peritoneal cavity through the surface area of the dialysate in the peritoneal cavity due to the high gradient of hydrostatic pressure. As some of the excess fluid may move to the peritoneal cavity by ultrafiltration (UF) during dwell, the dialysate is diluted and its density decreases, thereby causing the IPP to be inversely related to the UFV (Equation 6).
[0032] The goal of the bench study was to evaluate the relationship between pressure and dialysate height (Equation 2). For the bench study, the PD simulator 202 was filled with 2 L of 2.5% glucose dialysate. The height of the simulator was gradually increased in 2.5 inch steps until the highest point (36 inches) was reached. The highest height may correspond to a first state 201a in some instances. The height was then decreased from the highest point back to a baseline height over a period of 2 hours. The baseline height may correspond to a second state 201b in some instances. The pressure was measured automatically by the controller 206.
[0033] The bench study 200 included two stages of height change: stage (a) where the height increased from the baseline to the highest point (e.g., from the second state 201b to the first state 201a) and stage (b) where the height decreased from the highest point to the baseline (e.g., from the first state 201a to the second state 201b). FIGS. 3A and 3B illustrate the relationship between the change in height of the PD simulator 202 on the adjustable table 204 and the change in pressure measured by the controller 206 for each stage (a) and (b). As shown in FIGS. 3A and 3B, the pressure measured by the controller 206 was highly correlated with the height in both stages (a) and (b). The bench study 200 demonstrates that the change in pressure of the PD catheter can be closely measured using a pressure sensor, for example, a pressure sensor coupled to the controller 206.
[0034] Validation of IPP measurements using a sensor integrated into a Liberty cycler with software version 2.9.1C involved a clinical pilot study with 14 measurements in 12 PD patients (age 59.4 ± 14.3 years, 4 females, pre-weight 83 ± 28 kg, BMI 28.6 ± 7.8 kg / m2, PD history 13.3 ± 7 months) studied during a 2-h dwell (2 L dialysate, 2.5% dextrose). IPP was measured every 15 seconds using a pressure sensor integrated into the controller 206 (Liberty cycler with software version 2.9.1C). Three techniques were used to quantify UFV: (1) metering of the draining fluid (UFV Drain ), (2) with the Liberty cycler (UFV Liberty , in ml), and (3) by SBIA (UFV SBIA The mean UFV for all patients was UFV SBIA , U.F.V. Liberty , and U.F.V. Drain The UFV values were 199.1 ± 193.2 ml, 218.8 ± 136.4 ml, and 266.9 ± 136.4 g, respectively. Liberty (218.6±156.6ml) and UFVSBIA (198.1±215.6 ml) was UFV Drain When comparing IPV and IPP every 10 minutes, there was a correlation between IPV and IPP in 8 patients with UFV > 200 ml.
[0035] Figures 4A-8C illustrate results from bench study 200 and the clinical pilot study. As shown in Figure 4A, the IPV increased by 0.499 L (UFV) during the dwell. As shown in Figure 4B, the IPP decreased from 24.1 mbar to 18.6 mbar during the same time period. Figure 5A illustrates how the IPP decreased from the start of the dwell to the end of the dwell in a patient from the clinical study. Figure 5B illustrates how the change in dialysate density correlates with UFV in a patient from the clinical pilot study.
[0036] FIG. 6A illustrates the average IPV and IPP in eight patients during dwell, showing an increase in IPV (circles) and a decrease in IPP (squares). FIG. 6B illustrates the relationship between IPV and IPP during dwell in eight patients. In this example, each circle represents the relationship between the change in IPP and the change in IPV at different dwell times for the same patient. A dashed line connects two consecutive points in chronological order. As shown in FIG. 6B, IPP tends to decrease over time as IPV increases, and the change over time tends to be linear.
[0037] 7A and 7B show the IPP at the beginning of the dwell (IPP Start ) is UFV Liberty and U.F.V. SBIA (Figure 7B shows UFV BIA These results demonstrate that IPP values at the start of dwell can be used to predict UFV. In studies designed to provide the same dwell time for all patients, IPP Start The correlation between IPP and UFV Start The correlation between IPP and ultrafiltration rate (UFR) is almost the same as that between IPP and ultrafiltration rate (UFR). Assuming that UFR in PD may be related to fluid transport across the peritoneum, Startcan be a useful parameter for understanding the properties of the peritoneal membrane in individual patients (Equation 7). Figure 7A shows the IPP measured at the beginning of the dwell (IPP Start ) versus UFV by the Liberty cycler. The treatment time was the same for all patients, so that a different UFV corresponds to each individual UFR, which may reflect the individual membrane properties of each patient's respective membrane.
[0038] When the IPV increases, the density of the dialysate decreases depending on the amount of water that has transferred through the membrane, and the dialysate in the peritoneal cavity is diluted. P=ρ·g·h Equation 2 (restated) where P is the pressure of a particular fluid, ρ is the fluid density, g is the acceleration due to gravity, and h is the height of the fluid. If g and h are constant, then the pressure can decrease as the density decreases. The bench study 200 described above confirms this relationship. However, if the height (h) is not constant, then the pressure must be calculated using at least two variables (e.g., h and ρ). The following discussion demonstrates techniques for determining pressure using at least two variables and describes the results of bench studies that support the relationship between pressure, height, and volume.
[0039] From Equation 1, the following derivative equation can be obtained:
number
[0040] FIG. 11 illustrates another bench study 300 that was performed. The bench study 300 demonstrated that the change in IPP depends on the change in IPV. The bench study 300 includes a PD simulator 302, an adjustable table 304, and a controller 306. The controller 306 included a Liberty cycler with software version 2.9.3. The height of the adjustable table 304 remained unchanged for the duration of the experiment, so that for any two states 301a, 301b, the heights H1, H2 of each state are equal. The arrows 308 represent the change from a first state 301a to a second state 301b.
[0041] The controller 306 measured the IPP using sensors (e.g., pressure sensors and / or electrodes such as electrodes 102, 104). The PD simulator 302 was used to fill with a known dialysate solution (2000 mL). The experiment included three phases: (1) a fill phase (2 L of dialysate was filled into the simulator within 10 minutes), (2) a dwell phase of 25 minutes, and (3) a drain phase of approximately 10 minutes.
[0042] FIG. 12 is a plot of the results of the bench study 300. FIG. 12 illustrates the change in pressure during filling and draining of the PD simulator 302 during the bench study 300. FIG. 12 shows that the increase and decrease in IPP are due to the amount of fluid loaded (load) and removed (drain) from the PD simulator 302. It will be appreciated that during the dwell, there is no change in the volume or height of the PD simulator 302, and therefore the pressure of the fluid within the PD simulator 302 should otherwise remain constant. Thus, the bench study 300 provides evidence that the relationship between IPV and IPP can be expressed using a piecewise map that depends on at least two independent variables: the density of the solution and the height.
[0043] The above description describes the relationship between IPV and IPP during dwell time. The above description shows that ultrafiltration volume can be monitored by IPP measurement during peritoneal dialysis treatment. Since IPP measurement can be performed automatically using an integrated sensor in the PD device (such as the controller 112, 206, 306, or a device such as a Liberty cycler or similar device), there is little or no additional cost or time compared to methods using bioimpedance. Furthermore, IPP Start The correlation between IPP and UFV implies that the IPP measured at the beginning of the dwell can be associated with the properties of the peritoneal membrane. This finding may enable objective and quantitative information to be obtained about the transport properties of the peritoneal membrane. Furthermore, the discovery of the relationship between the change in dialysate density during dwell and UFV provides further opportunities to understand the dynamics of chemical transport through the membrane. Furthermore, it will be appreciated that the pressure sensor method does not require the use of many electrodes in the SBIA method, thus making the present method easier to perform at home compared to existing methods.
[0044] From the above, it will be understood that the IPV can be predicted based on the IPP during the fill, dwell, and drain phases. In some instances, the IPV can be predicted based on the IPP, since the IPV is linearly related to the IPP. As a result, dialysis and dialysis-related treatments can predict the IPV using the IPP over time through the fill, dwell, and drain phases, and can adjust the treatment based on the resulting prediction and pressure values. Predicting the IPV based on the IPP eliminates the need for electrodes, such as those used in the SBIA or using other methods.
[0045] Although IPP can be measured quasi-continuously and non-invasively by a pressure sensor, such as a pressure sensor placed in a PD cycler or on a PD catheter, the accuracy of using IPP to calculate IPV and predict UFV may be affected by changes in dialysate density, which results in changes in IPV. IPP=ρ·g·h Equation 2 (restated) where ρ is the dialysate density, g is the gravitational acceleration, and h is the height of the PD dialysate in the peritoneal cavity above the measurement point. The gravitational acceleration g is the same throughout, so changes in h and ρ are the factors that drive the IPP change. In the clinical study mentioned above, it was demonstrated that the decrease in density ρ is due to the movement of water into the peritoneal cavity and the uptake of glucose from the peritoneal cavity into the patient. Knowing the dwell density ρ and IPP, calculation of h (a metric related to IPV) can be made by solving Equation 2 for h as follows:
number
[0046] The volume (V) can be calculated by multiplying the cross-sectional area (A) by the height h, so that Equation 2 can be expressed as:
number
number
number
number
[0047] According to another embodiment, the method of PD treatment may include (periodically) monitoring the IPP and dialysate density during the dwell of the PD treatment. For example, the PD cycler or PD treatment system may be configured to periodically pump a sample of dialysate from the peritoneal cavity for density measurement during the dwell cycle and then return the dialysate sample to the peritoneal cavity. For example, the PD cycler may be programmed to remove and return a dialysate sample for density measurement every 30 minutes during the dwell. FIG. 8A is a chart of UF volume versus time during the dwell, and in FIG. 8A, exemplary time points at which periodic sampling of the dialysate fluid and density measurement may be performed automatically by the PD cycler or PD system are identified. FIG. 8A shows that the UFV first increases at a fairly fast rate (e.g., from 0 mL to about 450 mL over 120 minutes), and then the UFV decreases at a slower, constant rate (e.g., from 450 mL to about 350 mL over 150 minutes).
[0048] FIG. 8B shows a schematic diagram of a PD system 800 according to another embodiment. The PD system 800 may be capable of performing a PD treatment, and the PD system 800 may automatically sample and measure the density of the dialysate fluid periodically during a dwell phase. The PD system 800 includes a PD cycler 810 fluidly connected to a PD patient catheter 812 and a series of valves 814, 816, 818. The valves 814, 816, 818 are configured to control the flow of dialysate into and out of the catheter 812, as well as the opening and / or closing of a bag of fresh dialysate 820 and the opening and / or closing of a drain bag 822. The PD cycler 810 may include a pressure sensor (not shown) configured to measure the pressure of the fluid in the catheter 812. The PD system 800 further includes a flow sensor 824 configured and positioned to measure the flow rate and volume of dialysate flowing into or out of the patient's peritoneal cavity. In some embodiments, the PD system 800 includes a temperature sensor 826 configured to measure dialysate temperature and ambient temperature. In some examples, the PD cycler 810 controls the direction and time of dialysate flow into or out of the peritoneal cavity. The PD system 800 uses a bag of fresh dialysate 820 to temporarily contain the dialysate sample during the dwell cycle. The PD system 800 may further include a dialysate density measurement mechanism. For example, as shown in FIG. 8B, the PD system 800 may include a scale 828 configured to measure the weight of the dialysate sample when temporarily stored in the bag of fresh dialysate 820. In some embodiments, one or more of the components of the PD system 800 may be integrated into the PD cycler 810. For example, in some embodiments, the valves 814, 816, 818, the flow sensor 824, the temperature sensor 826, and / or the scale 828 are integrated into the PD cycler 810.
[0049] The PD system 800 can periodically measure the dialysate density by pumping a small dialysate sample from the patient's peritoneal cavity through a flow sensor 824 and into a bag of fresh dialysate 820. The flow measurement from the flow sensor 824 can be used to calculate the total volume of the dialysate sample, and the output from the scale 828 can be used to calculate the mass of the dialysate sample. The density ρ of the dialysate sample can then be calculated by dividing the mass of the dialysate sample by the volume of the dialysate sample. The sampling frequency and dialysate density measurements are adjustable parameters. For example, taking dialysate samples to determine the density of the dialysate sample can be done continuously or at intervals such as every 10 minutes, 15 minutes, 20 minutes, 25 minutes, 30 minutes, or more. In some embodiments, the PD system 800 is programmed to compensate the density and / or pressure measurements for temperature fluctuations. Temperature fluctuations can be monitored by a temperature sensor 826. In some embodiments, the PD system 800 is programmed to calculate the IPV after each dialysate sampling density calculation according to Equation 13 and monitor the IPV throughout the dwell cycle. When the target ultrafiltration rate is achieved, the dwell cycle ends.
[0050] Figure 8C is a chart showing the change in dialysate density at the start of the dwell and at the end of the dwell for 13 patients. Density decreased with fresh dialysate of 2.5% glucose from 1.018 (g / ml) to a mean of 0.9256 ± 0.0106 (g / ml) (p < 0.0001).
[0051] In some examples, the systems and methods described herein provide for monitoring changes in IPV and / or IPP based on changes in dialysate density. In some examples, the systems and methods described herein provide for predicting ultrafiltration rate (UFR) or ultrafiltration volume (UFV) based on IPP and / or dialysate density. The systems and methods described herein can be used to provide more effective PD treatment based on calculations of IPV, IPP, UFR, and / or UFV without requiring additional equipment that is impractical for home PD patients.
[0052] In one embodiment, the system includes one or more devices, including one or more hardware processors, configured to perform any of the operations described and / or claimed herein.
[0053] In one embodiment, one or more non-transitory computer-readable storage media store instructions that, when executed by one or more hardware processors, cause any of the operations described and / or claimed herein to be performed.
[0054] Any combination of the features and functions described herein may be used according to an embodiment. In the foregoing specification, the embodiments have been described with reference to numerous specific details that may vary from implementation to implementation. Therefore, the specification and drawings should be considered in an illustrative sense, not a limiting sense. The sole and exclusive indication of the scope of the invention, and what the applicant intends to be the scope of the invention, is the literal and equivalent scope of the set of claims issued from this application, the specific form in which such claims are issued, including any subsequent amendments.
[0055] In one embodiment, the techniques described herein are implemented by one or more special-purpose computing devices (i.e., computing devices specially configured to perform a particular function). The special-purpose computing device(s) may include digital electronic devices such as one or more application-specific integrated circuits (ASICs), field programmable gate arrays (FPGAs), and / or network processing units (NPUs) that may be hardwired to perform the techniques and / or permanently programmed to perform the techniques. Alternatively or additionally, the computing device may include one or more general-purpose hardware processors that are programmed to perform the techniques according to program instructions in firmware, memory, and / or other storage. Alternatively or additionally, the special-purpose computing device may combine custom hardwired logic, ASICs, FPGAs, or NPUs with custom programming to accomplish the techniques. The special-purpose computing device may include desktop computer systems, portable computer systems, handheld devices, networking devices, and / or any other device(s) that incorporate hardwired logic and / or program logic to implement the techniques.
[0056] 9 is a block diagram of an example of a computer system 900 according to one embodiment. The computer system 900 includes a bus 902 or other communication mechanism for communicating information, and a hardware processor 904 coupled to the bus 902 for processing information. The hardware processor 904 may be a general-purpose microprocessor.
[0057] Computer system 900 also includes a main memory 906, such as a random access memory (RAM) or other dynamic storage device, coupled to bus 902 for storing information and instructions executed by processor 904. Main memory 906 may also be used for storing temporary variables or other intermediate information during execution of instructions to be executed by processor 904. Such instructions, when stored in one or more non-transitory storage media accessible to processor 904, render computer system 900 into a special-purpose machine customized to perform operations specified in the instructions.
[0058] Computer system 900 further includes a read only memory (ROM) 908 or other static storage device, coupled to bus 902, for storing static information and instructions for processor 904. A storage device 910, such as a magnetic disk or optical disk, is provided and coupled to bus 902 for storing information and instructions.
[0059] The computer system 900 may be coupled via a bus 902 to a display 912, such as a liquid crystal display (LCD), plasma display, electronic ink display, cathode ray tube (CRT) monitor, or any other type of device for displaying information to a computer user. An input device 914, including alphanumeric and other keys, may be coupled to the bus 902 for communicating information and command selections to the processor 904. Alternatively or additionally, the computer system 900 may receive user input via a cursor control 916, such as a mouse, trackball, trackpad, or cursor direction keys, for communicating directional information and command selections to the processor 904 and for controlling cursor movement on the display 912. This input device typically has two degrees of freedom in two axes, a first axis (e.g., x) and a second axis (e.g., y), that allow the device to specify a position in a plane. Alternatively or additionally, the computer system 900 may include a touch screen. The display 912 may be configured to receive user input via one or more pressure-sensitive sensors, multi-touch sensors, and / or gesture sensors. Alternatively or additionally, computer system 900 may receive user input via a microphone, a video camera, and / or some other type of user input device (not shown).
[0060] The computer system 900 may implement the techniques described herein using customized hardwired logic, one or more ASICs or FPGAs, firmware, and / or program logic that, in combination with other components of the computer system 900, causes or programs the computer system 900 to be a special-purpose machine. According to one embodiment, the techniques herein are executed by the computer system 900 in response to the processor 904 executing one or more sequences of one or more instructions contained in the main memory 906. Such instructions may be read into the main memory 906 from another storage medium, such as the storage device 910. Execution of the sequences of instructions contained in the main memory 906 causes the processor 904 to perform the process steps described herein. Alternatively or additionally, hardwired circuitry may be used in place of or in combination with software instructions.
[0061] The term "storage medium" as used herein refers to one or more non-transitory media that store data and / or instructions that cause a machine to operate in a particular manner. Such storage media may comprise non-volatile media and / or volatile media. Non-volatile media include optical or magnetic disks, such as storage device 910. Volatile media include dynamic memory, such as main memory 906. Common forms of storage media include, for example, floppy disks, flexible disks, hard disks, solid state drives, magnetic tape or other magnetic data storage media, CD-ROM or any other optical data storage media, any physical media with patterns of holes, RAM, programmable read-only memory (PROM), erasable PROM (EPROM), FLASH-EPROM, non-volatile random access memory (NVRAM), any other memory chip or cartridge, content addressable memory (CAM), and ternary content addressable memory (TCAM).
[0062] Storage media is distinct from but may be used in conjunction with transmission media. Transmission media involves transferring information between storage media. Examples of transmission media include coaxial cables, copper wire, and fiber optics, including the wires that comprise bus 902. Transmission media can also take the form of acoustic or light waves, such as those generated during radio wave and infrared data communications.
[0063] Various forms of media may be involved in carrying one or more sequences of one or more instructions to the processor 904 for execution. For example, the instructions may initially be carried on a magnetic disk or solid state drive of a remote computer. The remote computer may load the instructions into its dynamic memory and send the instructions over a network via a network interface controller (NIC), such as an Ethernet controller or Wi-Fi controller. A NIC local to the computer system 900 may receive the data from the network and place the data on the bus 902. The bus 902 carries the data to the main memory 906, from which the processor 904 retrieves and executes the instructions. The instructions received by the main memory 906 may optionally be stored on a storage device 910 either before or after execution by the processor 904.
[0064] Computer system 900 also includes a communication interface 918 coupled to bus 902. The communication interface 918 provides a two-way data communication coupling to a network link 920 that is connected to a local network 922. For example, the communication interface 918 may be an Integrated Services Digital Network (ISDN) card, cable modem, satellite modem, or a modem to provide a data communication connection to a corresponding type of telephone line. As another example, the communication interface 918 may be a LAN card to provide a data communication connection to a compatible local area network (LAN). A wireless link may also be implemented. In any such implementation, the communication interface 918 sends and receives electrical, electromagnetic or optical signals that carry digital data streams representing various types of information.
[0065] The network link 920 typically provides data communication through one or more networks to other data devices. For example, the network link 920 may provide a connection through a local network 922 to a host computer 924 or to data equipment operated by an Internet Service Provider (ISP) 926. The ISP 926 in turn provides data communication services through the world wide packet data communications network now commonly referred to as the "Internet" 928. Both the local network 922 and the Internet 928 use electrical, electromagnetic or optical signals that carry digital data streams. The signals through the various networks and the signals on the network link 920 and through the communication interface 918, which carry the digital data to and from the computer system 900, are exemplary forms of transmission media.
[0066] Computer system 900 can send messages and receive data, including program code, through the network(s), network link 920 and communication interface 918. In the Internet example, a server 930 might transmit a requested code for an application program through the Internet 928, ISP 926, local network 922 and communication interface 918.
[0067] The received code may be executed by processor 904 as it is received, and / or stored in storage device 910, or other non-volatile storage for later execution.
[0068] In one embodiment, a computer network provides connectivity between a set of nodes executing software utilizing the techniques described herein. The nodes may be local and / or remote from one another. The nodes are connected by a set of links. Examples of links include coaxial cable, unshielded twisted cable, copper cable, optical fiber, and virtual links.
[0069] A subset of nodes implements a computer network. Examples of such nodes include switches, routers, firewalls, and network address translators (NATs). Another subset of nodes uses the computer network. Such nodes (also called "hosts") may execute client processes and / or server processes. Client processes make requests for computing services (e.g., requests to run a particular application and / or retrieve a particular data set). Server processes respond by performing the requested service and / or returning corresponding data.
[0070] A computer network may be a physical network that includes physical nodes connected by physical links. A physical node is any digital device. A physical node may be a specific-function hardware device. Examples of specific-function hardware devices include hardware switches, hardware routers, hardware firewalls, and hardware NATs. Alternatively or additionally, a physical node may be any physical resource that provides computing power to perform a task, such as those configured to run various virtual machines and / or applications that perform respective functions. A physical link is a physical medium that connects two or more physical nodes. Examples of links include coaxial cable, unshielded twisted cable, copper cable, and optical fiber.
[0071] A computer network may be an overlay network. An overlay network is a logical network implemented on top of another network (e.g., a physical network). Each node in the overlay network corresponds to a respective node in the underlying network. Thus, each node in the overlay network is associated with both an overlay address (for addressing the overlay node) and an underlay address (for addressing the underlay node that implements the overlay node). The overlay nodes may be digital devices and / or software processes (e.g., virtual machines, application instances, or threads). The links connecting the overlay nodes may be implemented as tunnels through the underlying network. The overlay nodes at both ends of the tunnel may treat the underlying multi-hop path between them as a single logical link. Tunneling is achieved through encapsulation and decapsulation.
[0072] In one embodiment, the client may be local and / or remote to the computer network. The client may access the computer network through a private network or other computer network, such as the Internet. The client may communicate requests to the computer network using a communication protocol, such as the Hypertext Transfer Protocol (HTTP). The request is communicated through an interface, such as a client interface (such as a web browser), a program interface, or an application programming interface (API).
[0073] In one embodiment, a computer network provides connectivity between clients and network resources. The network resources include hardware and / or software configured to execute server processes. Examples of network resources include processors, data storage, virtual machines, containers, and / or software applications. The network resources may be shared among multiple clients. The clients request computing services from the computer network independently of one another. The network resources are dynamically allocated to requests and / or clients on an on-demand basis. The network resources allocated to each request and / or client may be scaled up or down based on, for example, (a) the computing services requested by a particular client, (b) the aggregated computing services requested by a particular tenant, and / or (c) the requested aggregated computing services of the computer network. Such a computer network may be referred to as a "cloud network."
[0074] In one embodiment, a service provider provides a cloud network to one or more end users. Various service models may be implemented by the cloud network, including but not limited to Software-as-a-Service (SaaS), Platform-as-a-Service (PaaS), and Infrastructure-as-a-Service (IaaS). In SaaS, the service provider provides end users with the ability to use the service provider's applications running on the network resources. In PaaS, the service provider provides end users with the ability to deploy custom applications on the network resources. The custom applications may be created using programming languages, libraries, services, and tools supported by the service provider. In IaaS, the service provider provides end users with the ability to provision the processing, storage, network, and other basic computing resources provided by the network resources. Any application, including an operating system, may be deployed on the network resources.
[0075] In one embodiment, various deployment models may be implemented by the computer network, including but not limited to private cloud, public cloud, and hybrid cloud. In a private cloud, network resources are provisioned for exclusive use by a specific group of one or more entities (the term "entity" as used herein refers to a company, organization, person, or other entity). The network resources may be local and / or remote to the premises of the specific group of entities. In a public cloud, cloud resources are provisioned for multiple entities (also called "tenants" or "customers") that are independent of each other. In a hybrid cloud, the computer network includes a private cloud and a public cloud. An interface between the private cloud and the public cloud enables data and application portability. Data stored in the private cloud and data stored in the public cloud may be exchanged through an interface. Applications implemented in the private cloud and applications implemented in the public cloud may have dependencies on each other. Invocations from applications in the private cloud to applications in the public cloud (and vice versa) may be performed through an interface.
[0076] In one embodiment, the system supports multiple tenants. A tenant is a company, organization, enterprise, business unit, employee, or other entity that accesses shared computing resources (e.g., computing resources shared in a public cloud). One tenant may be separate from another tenant (through operations, tenant-specific practices, employees, and / or identification to the outside world). The computer network and its network resources are accessed by clients corresponding to different tenants. Such a computer network may be referred to as a "multi-tenant computer network." Several tenants may use the same particular network resource at different times and / or simultaneously. The network resource may be local and / or remote to the tenant's premises. Different tenants may require different network requirements for the computer network. Examples of network requirements include processing speed, amount of data storage, security requirements, performance requirements, throughput requirements, latency requirements, resiliency requirements, quality of service (QoS) requirements, tenant isolation, and / or consistency. The same computer network may need to implement different network requirements required by different tenants.
[0077] In one embodiment, in a multi-tenant computer network, tenant isolation is implemented to ensure that applications and / or data of different tenants are not shared with each other. Various tenant isolation techniques may be used. In one embodiment, each tenant is associated with a tenant ID. Applications implemented by the computer network are tagged with a tenant ID. Additionally or alternatively, data structures and / or data sets stored by the computer network are tagged with a tenant ID. A tenant is permitted to access a particular application, data structure, and / or data set only if the tenant and the particular application, data structure, and / or data set are associated with the same tenant ID. As an example, each database implemented by the multi-tenant computer network may be tagged with a tenant ID. Only tenants associated with the corresponding tenant ID may access the data of a particular database. As another example, each entry in a database implemented by the multi-tenant computer network may be tagged with a tenant ID. Only tenants associated with the corresponding tenant ID may access the data of a particular entry. However, a database may be shared by multiple tenants. A subscription list may indicate which tenants have permission to access which applications. For each application, a list of tenant IDs of tenants authorized to access the application is stored. A tenant is granted access to a particular application only if the tenant's tenant ID is included in the subscription list corresponding to that particular application.
[0078] In one embodiment, network resources (such as digital devices, virtual machines, application instances, and threads) corresponding to different tenants are separated into tenant-specific overlay networks maintained by a multi-tenant computer network. As an example, packets from any source device in a tenant overlay network may be sent only to other devices in the same tenant overlay network. An encapsulation tunnel may be used to prohibit any transmission from a source device on a tenant overlay network to devices in other tenant overlay networks. Specifically, a packet received from a source device is encapsulated in an outer packet. The outer packet is sent from a first encapsulation tunnel endpoint (communicating with a source device in a tenant overlay network) to a second encapsulation tunnel endpoint (communicating with a destination device in a tenant overlay network). The second encapsulation tunnel endpoint decapsulates the outer packet to obtain the original packet sent by the source device. The original packet is sent from the second encapsulation tunnel endpoint to a destination device in the same specific overlay network.
[0079] FIG. 10 is a block diagram of an example of a connected health (CH) system 1000 according to an embodiment. In an embodiment, the CH system 1000 may include more or less components than those illustrated in FIG. 10. The components illustrated in FIG. 10 may be local or remote from one another. The components illustrated in FIG. 10 may be implemented in software and / or hardware. Each component may be distributed across multiple applications and / or machines. Multiple components may be combined into one application and / or machine. Operations described with respect to one component may instead be performed by another component.
[0080] The CH system 1000 may be configured to be part of or communicate with a system such as the system 100. The CH system 1000 may include, among other things, a processing system 1005, a CH cloud service 1010, and a gateway (CH gateway) 1020 that may be used in connection with network aspects of one or more systems described herein. The processing system 1005 may include a server and / or cloud-based system that processes, compatibility checks, and / or formats medical information, including prescription information, generated in a clinic or hospital clinical information system (CIS) 1004 in connection with the data transmission operations of the CH system 1000. The CH system 1000 may include appropriate encryption and data security mechanisms. The CH cloud service 1010 may include a cloud-based application that serves as a communication pipeline (e.g., facilitates the transfer of data) between components of the CH system 1000 via a connection to a network such as the Internet. The gateway 1020 may serve as a communication device that facilitates communication between components of the CH system 1000. In various embodiments, the gateway 1020 may communicate with the dialysis machines 1002 (e.g., peritoneal dialysis machines or hemodialysis machines) and the system 100 via a wireless connection 1001, such as Bluetooth, Wi-Fi, and / or other suitable types of local or short-range wireless connections. The gateway 1020 may also connect to the CH cloud service 1010 via a secure network (e.g., Internet) connection. The gateway 1020 may be configured to send / receive data to / from the CH cloud service 1010 and to / from the dialysis machines 10010 and the system 100. The dialysis machines 1002 may poll the CH cloud service 1010 (e.g., via the gateway 1020) for available files, and the dialysis machines 1002 and / or the system 100 may temporarily store available files for processing.
[0081] It will be understood that the above references specific hardware such as the Liberty cycler and the Hydra 4200. It will be understood that the above does not require a Liberty cycler or a Hydra 4200, but rather that these devices are merely examples of devices that may be used in the capacity described with respect thereto herein. Other devices, combinations of devices, or systems having equivalent or similar functionality may be used.
Claims
1. 1. A method for monitoring intraperitoneal volume (IPV) of fluid during a dwell period of a peritoneal dialysis treatment, comprising: monitoring an intraperitoneal pressure (IPP) of said fluid during said dwell period using a pressure sensor; measuring the volume and weight of at least one sample of said fluid during said residence time; determining a density of the fluid during the residence time based on the volume and the weight of the at least one sample; determining an IPV based at least on a change in IPP during said dwell period and on said change in density; A method comprising:
2. The IPV is [0010] where V 0 is the volume of the fluid at the beginning of the dwell period, and IPP 0 is the intraperitoneal pressure at the start of the dwell period, and ρ 0 is the known density of the fluid at the start of the dwell period, and ρ is the density of the fluid during the dwell period. The method of claim 1.
3. 2. The method of claim 1, wherein determining the density of the fluid during the residence time comprises extracting at least one sample of the fluid from the patient's peritoneal cavity, determining the volume of the at least one sample and a mass of the at least one sample, and returning the at least one sample to the peritoneal cavity.
4. 4. The method of claim 3, wherein the drawing of the at least one sample of the fluid is performed automatically and the dwell period ends when an ultrafiltration volume (UFV) reaches a target UFV, the UFV being calculated by subtracting an initial fill volume of the fluid from the IPV.
5. The method of claim 1 , wherein the density is determined periodically.
6. The method of claim 5 , wherein periodically determining the density comprises determining the density every 30 minutes.
7. 10. The method of claim 1, wherein the IPP is measured by measuring the pressure of the fluid in a peritoneal dialysis catheter.
8. The method of claim 1 , further comprising compensating the IPP and the density for variations in temperature of the fluid.
9. a pressure sensor configured to measure an intraperitoneal pressure (IPP) of a fluid; A controller; The controller comprises: monitoring an intraperitoneal volume (IPV) of said fluid during a patient dwell period by at least monitoring said IPP during said dwell period using said pressure sensor; determining a density of the fluid during the residence time based on a volume and weight of at least one sample of the fluid; determining a change in the IPV based at least on a change in the IPP and a change in the density of the fluid during the dwell period; The peritoneal dialysis cycler is configured to:
10. The controller: [0025] wherein V is programmed to determine the IPV using a formula comprising: 0 is the volume of the fluid at the beginning of the dwell period, and IPP 0 is the IPP at the beginning of the dwell period, and ρ 0 is the known density of the fluid at the start of the dwell period, and ρ is the density of the fluid during the dwell period.
10. The peritoneal dialysis cycler of claim 9.
11. 10. The peritoneal dialysis cycler of claim 9, wherein determining the density of the fluid during the dwell period comprises extracting the at least one sample from a patient's peritoneal cavity, determining the volume of the at least one sample and the mass of the at least one sample, and then returning the at least one sample to the peritoneal cavity.
12. 12. The peritoneal dialysis cycler of claim 11, wherein the drawing of the at least one sample of the fluid is performed automatically and the dwell ends when an ultrafiltration volume (UFV) reaches a target UFV, the UFV being calculated by subtracting an initial fill volume of the fluid from the IPV.
13. 12. The peritoneal dialysis cycler of claim 11, wherein the volume of the at least one sample is calculated based on a flow sensor measurement of the fluid extracted from the peritoneal cavity and the mass of the fluid is determined using a scale to measure the weight of the at least one sample.
14. 10. The peritoneal dialysis cycler of claim 9, further comprising a temperature sensor configured to measure a temperature of the fluid.
15. 15. The peritoneal dialysis cycler of claim 14, wherein the controller compensates the pressure and the density based on a temperature of the fluid.
16. The peritoneal dialysis cycler of claim 9 , wherein the controller is configured to periodically determine the density.
17. One or more non-transitory computer-readable media having instructions stored thereon that, when executed by one or more processors, cause the one or more processors to: determining an intraperitoneal pressure (IPP) of the fluid during a dwell period using a pressure sensor; determining a change in the IPV based at least on a change in the IPP of the fluid during the dwell period; determining a density of the fluid during the residence time based on a volume and weight of at least one sample of the fluid; determining an intraperitoneal volume (IPV) of the fluid based at least on the change in IPP and the change in density during the dwell period; A non-transitory computer-readable medium for causing a computer to perform operations comprising:
18. The instructions cause the one or more processors to: [0030] and further instructing the device to determine the IPV using a formula comprising: 0 is the volume of the fluid at the beginning of the dwell period, and IPP 0 is the IPP at the beginning of the dwell period, and ρ 0 is the known density of the fluid at the start of the dwell period, and ρ is the density of the fluid during the dwell period.
20. The non-transitory computer-readable medium of claim 17.
19. The instructions cause the one or more processors to: Extracting at least one sample of said fluid from the patient's peritoneal cavity; determining the volume of the at least one sample; determining a mass of the at least one sample; returning the at least one sample to the peritoneal cavity; 20. The non-transitory computer-readable medium of claim 17, further instructing the computer to:
20. 20. The non-transitory computer-readable medium of claim 17, wherein the instructions further instruct the one or more processors to compensate for the density and the IPP based on a temperature of the fluid.
Citation Information
Patent Citations
Apparatus for performing peritoneal dialysis
JP2020520268A
Peritoneal dialysate flow path sensing
US20210178043A1
